Company

GRIK Therapeutics

Biotechnology Research Boston, Massachusetts, United States 5 employees

Employees: 5
Contacts: 3
Emails: 3
Phones: 1

GRIK Therapeutics Overview

Headquarters: Boston, Massachusetts, United States
Industry: Biotechnology Research
Employees: 5
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Neurobiology Biotechnology Pharmaceutical Science Pharmacology Rare Disease Electrophysiology Ion Channels Neuroscience CNS Epilepsy Computational Models Drug Discovery

About GRIK Therapeutics

GIRK Therapeutics is a pre-clinical stage therapeutics company focused on leveraging and integrating computation, electrophysiology and cortical circuit neurobiology to create the next generation of highly selective molecules for diseases with unmet needs. Harnessing the complexity of ion channels we have built a computational platform that links the binding of allosteric modulators to ion channel function, in-silico. With this approach we can generate treatments for neuroscience and brain health diseases that have been historically difficult to treat efficaciously.

GRIK Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

GRIK Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Scott Filosi	Chief Executive Officer I CEO I		View
Mike Ackley	Leader in Neuroscience Drug Discovery	Cambridge, Massachusetts, United States	Email Phone
Steve Swann	A Drug Discovery Leader	Greater Boston, United States	Email
Scott Mcmenemy	Innovation - Business Development	Greater Boston, United States	Email